Effect of Deep sea water, Activated Charcoal on Cholesterol in Hyperlipidemic subjects
Main Article Content
Abstract
This research was designed to study the effect of deep sea water (DSW) and activated charcoal (AC) on hyperlipidemic subjects. Levels of cholesterol, HDL, LDL, and triglycerides were tested at the beginning and end of 14 days. The subjects were divided into three groups.The first group was asked to consume deep sea water which had mild traces of magnesium (2% in a 240ml serving; 1800ml to be consumed per day); the second group was asked to consume charcoal capsules (260 mg three times a day), and a third group was the control group. The groups consumed deep sea water and activated charcoal for 14 days. Cholesterol pre- and post-examination revealed that deep sea water or activated charcoal had no significant effect on reduction or regulation of cholesterol levels.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright: Asia-Pacific International University reserve exclusive rights to publish, reproduce and distribute the manuscript and all contents therein.
References
Godin, G. (2011). The Godin-Shiphard Leisure-Time Physical Activity Questionnaire. Health & Fitness Journal of Canada, 4(1), 18-22.
Holt-Lunstad, J., Steffen, P. R., Sandberg, J. & Jensen, B. (2011). Understanding the connection between spiritual well-being and physical health: an examination of ambulatory blood pressure, inflammation, blood lipids and fasting glucose. Journal of Behavioral Medicine, 34(6), 477-88. doi: 10.1007/ s10865-011-9343-7.
Koenig, H. G. (2012). Religion, spirituality, and health: The research and clinical implications. International Scholarly Research Network (ISRN) Psychiatry, 1-33.
Kuusisto, P., Manninen, V. , Vapaatalo, H. , Huttunen, J. & Neuvonen, P. (1986). Effect of activated charcoal on hypercholesterolaemia. The Lancet, 328(8503), 366-367. doi: 10.1016/S0140-6736(86)90054-1.
Middle East Health. (2013). Global Health Data: WHO updates data on leading causes of death. Retrieved Oct, 2013, from http://www.middleeasthealthmag.com/sep2013/feature3.htm
Morris, J. D. (2004). Does the Similarity of Human Blood to Sea Water Prove Life Originated in the Ocean?. Acts & Facts. 33(2). Retrieved April, 2013, from http://www.icr.org/article/does-similarity-humanblood-sea-water-prove-life-o/
Neuvonen, P.J., Kuusisto, P., Manninen, V., Vapaatalo, H. & Miettinen, T.A. (1989). The mechanism of the hypocholesterolaemic effect of activated charcoal. European Journal of Clinical Investigation, 19(3), 251-254.
Naewbood, S., Sorajjakool , S., & Kantharadussadee, T. S. (2012). The Role of Religion in Relation to Blood Pressure Control among a Southern California Thai Population with Hypertension. Journal of Religion and Health 5,187–197. doi:10.1007/s10943-010-9341-z.
National Institutes of Health office of Dietary Supplements. (2013). Magnesium Fact Sheet for Health Professionals. Retrieved November, 2013 from, http://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/
President and fellows of Harvard College. (2008). Harvard Heart Letter, Harvard Health Publication. 18(5), 7.
Radhakrishnan, G., et al. (2009). Intake of dissolved organic matter from deep seawater inhibits atherosclerosis progression. Biochemical and Biophysical Research Communications, 387(1), 25-30.
Santo, H. (n.d.). Fat Intake Questionnaire. Retrieved March, 2013, from http://www.heidi.com.au/articles.
Sheu, M. J., Chou, P.Y., Lin, W.H., Pan, C.H., Chien, Y.C., Chung, Y.L., et al.. (2013). Deep Sea Water Modulates Blood Pressure and Exhibits Hypolipidemic Effects via the AMPK-ACC Pathway: An in Vivo Study. Mar. Drugs, 11(6), 2183-2202. doi:10.3390/md11062183.
Taiwan Yes. (2013). What is Deep Ocean Water (DOW)? Retrieved March, 2013, from http://www.taiwanyes -dow.com.tw/eng/deepwater_3.php
WHO. (2012). The top 10 causes of death. Retrieved March, 2013, from http://www.who.int/mediacentre/ factsheets/fs310/en/
YOSHIOKA S., et al. (2003). Pharmacological Activity of Deep-Sea Water: Examination of Hyperlipemia Prevention and Medical Treatment Effect. Biol. Pharm. Bull., 26(11), 1552-1559.